Gynecologic Oncology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

FDA Alert
FDA logo on website
FDA Alert
FDA Approves Datopotamab Deruxtecan-dlnk (Datroway) for Unresectable or Metastatic Triple-Negative Breast Cancer
05/22/2026
Anthony Calabro, MA
On May 22, 2026, the FDA approved datopotamab deruxtecan-dlnk for adults with unresectable or metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitor therapy, based on...
05/22/2026
ASCO CONFERENCE COVERAGE
food pictured from above
ASCO CONFERENCE COVERAGE
Lifestyle Program Improves Cardiometabolic Outcomes in Survivors of Breast Cancer
05/22/2026
Anthony Calabro, MA
In a phase 3 randomized trial of women with stage I-III breast cancer, a low-glycemic Mediterranean diet, brisk walking, and vitamin D did not reduce recurrence overall but improved weight and metabolic...
05/22/2026
ASCO CONFERENCE COVERAGE
WOMEN USING STATIONARY BIKES
ASCO CONFERENCE COVERAGE
Phase 3 BWEL Substudy: Weight Loss Intervention Improves QOL in Stage II-III Breast Cancer
05/22/2026
Anthony Calabro, MA
In a phase 3 BWEL substudy, a lifestyle-based weight loss intervention improved patient-reported physical function, global health, social roles and activities, and fatigue in women with stage II-III breast...
05/22/2026

Interactive Features

Quiz Series
patient in hospital bed
Quiz Series
Evolving Patterns of Neoadjuvant Systemic Therapy in US Cancer Care
03/05/2026
Anthony Calabro, MA
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
03/05/2026
3-in-30
clinician writing with model of uterus in background
3-in-30
Are You Missing Opportunities to Assess and Prevent High-Grade Serous Ovarian Cancer?
02/20/2026
Kate Young
According to research published in JAMA Surgery, missed opportunities for risk assessment and surgical prevention are common among ovarian cancer patients with high-grade serous cancer (HGSC). Take this...
02/20/2026
Slideshow
breast cancer awareness month pin on keyboard
Slideshow
A Look Back at Breast Cancer Awareness Month
10/27/2025
Kate Young
October is Breast Cancer Awareness Month. Swipe through this slideshow to explore our latest coverage highlighting the evolving science shaping breast cancer care today from approaches to surgery and...
10/27/2025
Pop Quiz
endometrial cancer
Pop Quiz
Endometrial Cancer Risk Factors
06/26/2025
Kate Young
Endometrial cancer risk can be influenced by genetic, hormonal, and metabolic factors, and understanding which can be crucial to prevention and early detection. Do you know the risk factors for endometrial...
06/26/2025
Pop Quiz
doctor completing paperwork
Pop Quiz
Postmenopausal Bleeding as a Symptom of Endometrial Cancer
01/20/2025
Anthony Calabro, MA
Researchers recently published a survey that aimed at evaluating public awareness of postmenopausal bleeding as a symptom of endometrial cancer. Do you know the survey findings? Test your knowledge with...
01/20/2025

Clinical Insights

Video
Brian M. Slomovitz, MD
Video
Investigating Immunotherapy and Chemotherapy in Endometrial Cancer Outcomes
03/03/2026
Brian M. Slomovitz, MD
In this video, Brian M. Slomovitz, MD, discusses his recent study demonstrating a significant improvement in disease-free survival with pembrolizumab in patients with dMMR endometrial cancer. He explains...
03/03/2026
conference coverage
chris dagher
conference coverage
Outcomes of Minimally Invasive Surgery vs Laparotomy for Stage II Endometrial Cancer
10/21/2024

Christian Dagher, MD

Christian Dagher, MD
In this video, Christian Dagher, MD, discusses the results of his team's study comparing the oncologic outcomes associated with treatment of stage II endometrial cancer with minimally invasive surgery vs...
10/21/2024
Cardiometabolic Risk
kara michels, phd
Cardiometabolic Risk
Metabolic Syndrome and Ovarian Cancer Risk
08/06/2022
Dr Michels shared important findings and implications from her new study on whether metabolic syndrome is associated with ovarian cancer risk.
08/06/2022